Will you still get your ADHD prescription online?
The federal rule that lets a prescriber write for ADHD medication over video, with no in-person visit first, has an end date on it. Three taps tells you whether you are in the group that has to do something about it, and what your own state adds on top. No signup, nothing leaves your browser.
1. Has the prescriber who signs your prescription ever examined you in person?
Not the clinic, not a different doctor. The person whose name is on the prescription.
2. Which state are you in?
Some states add their own in-person rule on top of the federal one, and a few are much stricter than the rest.
3. Who writes the prescription?
In two states this changes the answer.
The one appointment that ends the problem
One in-person exam with your own prescriber, on the record, before 31 December 2026. After that the requirement is met for good, whatever the DEA decides. Here is the message, already written.
What is actually happening
Before 2020, a prescriber had to examine you in person at least once before they could prescribe a controlled medication remotely. That is the Ryan Haight Act, and ADHD stimulants are controlled medication. During the pandemic the requirement was waived, and the waiver has been extended four times since. The fourth extension was published on 31 December 2025 and covers prescribing up to 31 December 2026.
So there is now a large group of people whose entire care has happened over video and who have never been examined in person by the person prescribing for them. If the extension is not renewed and the permanent rule is not finished, the old requirement returns for that group on 1 January 2027. Everyone who has had one in-person exam is already outside the problem, which is why that is the first question this page asks.
Two things could stop it: a fifth extension, or the DEA finalising the special registration for telemedicine it has been drafting. The proposal drew 6,475 comments and has not been finalised. Both are possible. Neither is a plan you control, and one appointment is.
Why the state answer is separate
The federal rule sets a floor, not a ceiling. A state can be stricter, and several are. New Jersey wants an in-person exam first and another one every three months. Ohio lets a board require an in-person visit before a new patient gets a Schedule II medication. Arkansas does not let a physician prescribe a controlled medication by telemedicine at all without an exam or a referral. In most states there is nothing extra, and the checker says so plainly rather than leaving you to wonder.
Questions people actually ask
Is my prescription about to be cancelled?
No. Nothing changes before 31 December 2026. The rule in force right now lets a prescriber start you on ADHD medication and keep prescribing it over video, with no in-person visit first. The question this page answers is what happens the day after.
What actually happens on 1 January 2027?
If the flexibility is not extended again and no permanent rule replaces it, the older law comes back. That law says a prescriber has to have done at least one in-person medical exam of you before prescribing a controlled medication remotely, apart from a short list of special situations such as care inside a hospital, an Indian Health Service site or the VA. The industry name for that day is the telemedicine cliff.
Does a visit with any doctor count?
No. It is the prescriber who signs your prescription who needs to have examined you in person. An appointment with your family doctor, a therapy session, or a nurse taking your blood pressure at the same clinic is not the same thing. If you are not sure, ask the clinic that exact question and write down the answer.
Will there be another extension?
Nobody knows, and anyone who tells you they do is guessing. There have been four temporary extensions so far, the most recent published on 31 December 2025. The DEA also has a permanent special registration for telemedicine in the works, which drew 6,475 public comments and has not been finalised. Either could land before the deadline.
Does this affect non-stimulant ADHD medication?
No. Atomoxetine, viloxazine and guanfacine are not controlled substances, so none of this applies to them. It is the stimulants, which are Schedule II, that the rule is about.
Is this legal or medical advice?
No. This is a plain reading of a published federal rule and of state summaries, with the date it was checked printed next to it. Your prescriber and their clinic are the people who have to follow these rules and they are the ones to ask. Nothing here is a reason to change or stop taking a medication.